Ex­clu­sive: BigHat inks Lil­ly deal for AI-boost­ed an­ti­bod­ies, ex­tends Se­ries B

Last month
Financing
AI

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Last month
R&D

Ex­clu­sive: Charm Ther­a­peu­tic­s' founder steps down as CEO, as AI biotech eyes clin­ic in 2026

Last month
People
AI

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

Last month
R&D

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

Last month
Pharma
FDA+

No­var­tis ter­mi­nates knee pain study; Telix re­ports brain tu­mor da­ta

Last month
News Briefing

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

Last month
Financing
Startups

Ayr­mid miss­es dead­line for de­tailed of­fer to top pri­vate eq­ui­ty bid for blue­bird

Last month
Deals
Cell/Gene Tx

Biotechs start to dis­close tar­iff ex­po­sure with US trade in­quiry un­der­way 

Last month
Pharma
Manufacturing

Gly­comine rais­es $115M to see if it can treat rare gly­co­sy­la­tion dis­or­der

Last month
Financing
Startups

GeneDx to buy Fab­ric Ge­nomics for up to $51M

Last month
Deals
Diagnostics

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

Last month
Pharma
FDA+

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

Last month
Pharma
Law

Click gets FDA au­tho­riza­tion for pre­ven­tive mi­graine dig­i­tal ther­a­peu­tic

Last month
FDA+
Health Tech

Leqem­bi wins EU au­tho­riza­tion for some Alzheimer's pa­tients, giv­ing Bio­gen, Ei­sai a boost over Lil­ly

Last month
Pharma
FDA+

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Last month
Pharma
Manufacturing

Con­gress should bar PBMs from own­ing phar­ma­cies, state at­tor­neys urge

Last month
Pharma

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

Last month
Pharma
Manufacturing

Boehringer's bis­pe­cif­ic pact with Cue Bio­phar­ma; He­paRe­geniX rais­es €21.5M

Last month
News Briefing

Mur­al On­col­o­gy ends clin­i­cal de­vel­op­ment, lays off most work­ers

Last month
People
R&D

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Last month
R&D

FDA clears clin­i­cal tri­al of gene-edit­ed pig liv­er used out­side of body

Last month
R&D

At­tovia col­lects an­oth­er $90M for I&I bi­o­log­ics in third fund­ing round in two years

Last month
Financing
Startups

J&J, phar­ma's earn­ings bell­wether, main­tains guid­ance as tar­iffs loom

Last month
Pharma
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times